95. 自己免疫性肝炎 Autoimmune hepatitis Clinical trials / Disease details

臨床試験数 : 52 / 薬物数 : 68 - (DrugBank : 27) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04933292 (ClinicalTrials.gov)	June 16, 2021	1/5/2020	A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome	A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome	Autoimmune Hepatitis;Primary Biliary Cirrhosis	Drug: Methylprednisolone and Mycophenolate mofetil;Drug: Methylprednisolone and azathioprine	Xiaoli Fan	NULL	Recruiting	18 Years	70 Years	All	78	Phase 4	China
2	NCT04376528 (ClinicalTrials.gov)	June 16, 2021	3/5/2020	Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy	Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Duo to Nonresponse to Standard Therapy	Hepatitis, Autoimmune;Primary Biliary Cholangitis;Immunosuppression	Drug: Cyclosporin A;Drug: Mycophenolate Mofetil	West China Hospital	NULL	Recruiting	18 Years	70 Years	All	89	Phase 4	China
3	EUCTR2016-001038-91-BE (EUCTR)	12/02/2018	30/06/2017	A study to investigate whether mycophenolate mofetil is more effective than azathioprine in patients with autoimmune hepatitis	A randomised, open-label clinical trial assessing the efficacy and safety of mycophenolate mofetil versus azathioprine for induction of remission in treatment naive autoimmune hepatitis - CAMARO	Autoimmune hepatitis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: mycophenolate mofeti Product Name: mycophenolate mofetil INN or Proposed INN: mycophenolate mofetil Other descriptive name: MYCOPHENOLATE MOFETIL Trade Name: azathioprine Product Name: azathioprine INN or Proposed INN: azathioprine Other descriptive name: AZATHIOPRINE Trade Name: prednisolone Product Name: prednisolone INN or Proposed INN: Prednisolone Other descriptive name: PREDNISOLONE SODIUM SUCCINATE	Leiden university medical centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	70	Phase 4	Belgium;Netherlands
4	NCT02900443 (ClinicalTrials.gov)	January 2017	17/8/2016	Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis	A Randomised, Open-label Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Naive Autoimmune Hepatitis	Autoimmune Hepatitis	Drug: Mycophenolate mofetil;Drug: Azathioprine	Radboud University Medical Center	Leiden University Medical Center	Recruiting	18 Years	N/A	All	70	Phase 4	Belgium;Netherlands
5	EUCTR2016-001038-91-NL (EUCTR)	18/11/2016	25/10/2016	A study to investigate whether mycophenolate mofetil is more effective than azathioprine in patients with autoimmune hepatitis	A randomised, open-label clinical trial assessing the efficacy and safety of mycophenolate mofetil versus azathioprine for induction of remission in treatment naive autoimmune hepatitis - CAMARO	Autoimmune hepatitis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: mycophenolate mofeti Product Name: mycophenolate mofetil INN or Proposed INN: mycophenolate mofetil Other descriptive name: MYCOPHENOLATE MOFETIL Trade Name: azathioprine Product Name: azathioprine INN or Proposed INN: azathioprine Other descriptive name: AZATHIOPRINE Trade Name: prednisolone Product Name: prednisolone INN or Proposed INN: Prednisolone Other descriptive name: PREDNISOLONE SODIUM SUCCINATE	Leiden university medical centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Netherlands

先頭へ